Small Molecules and/or Biologics Medicinal Chemistry Consultant Support Services

Closed Solicitation Posted

Solicitation number
75N95023Q00081
Agency
Responses due
Set-aside
Total Small Business

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health, through the National Institute on Drug Abuse, is seeking proposals from qualified small businesses to provide Medicinal Chemistry consultant support services. Consultants will provide technical guidance and recommendations to the NIH Blueprint Neurotherapeutics Network drug discovery programs, Help End Addiction Long-Term initiative for developing non-addictive pain therapies, and other NIH neuroscience drug development efforts. Proposals will be evaluated based on personnel qualifications and experience, technical approach, communication skills, price, and past performance, with a deadline of February 3, 2023.

The contract is set aside for small businesses and has a NAICS code of 541715 with a PSC code of R425. It is a level of effort contract with a base year and two option years not to exceed 800 labor hours and $1,500 per period for travel costs. The primary place of performance will be the contractor's site with potential work also taking place at government or grantee facilities. Consultants will advise on project milestones and testing, evaluate structure-activity relationship data, and facilitate discussions to support lead development.

Notice text

3 versions

Update #3 · Latest ·

Statement of Need and Purpose: The NIH is seeking executive (senior scientific)-level, industry-experienced drug discovery and development consultants with expertise in Medicinal Chemistry to provide technical guidance in the area of Medicinal Chemistry to the following programs:
• Medicinal Chemistry consulting to procure consultant services to provide technical recommendations to the NIH Blueprint Neurotherapeutics Network drug discovery and development programs.
• Help End Addiction Long-Term [HEAL] initiative. The HEAL initiative aims to optimize non-addictive therapies [small molecules and biologics] to treat pain.
• Other NIH neuroscience-focused drug discovery and development programs.

Amendment 1 Attached - Q&A posted

Amendment 2 Attached - Q&A posted

Update #2 ·

Statement of Need and Purpose: The NIH is seeking executive (senior scientific)-level, industry-experienced drug discovery and development consultants with expertise in Medicinal Chemistry to provide technical guidance in the area of Medicinal Chemistry to the following programs:
• Medicinal Chemistry consulting to procure consultant services to provide technical recommendations to the NIH Blueprint Neurotherapeutics Network drug discovery and development programs.
• Help End Addiction Long-Term [HEAL] initiative. The HEAL initiative aims to optimize non-addictive therapies [small molecules and biologics] to treat pain.
• Other NIH neuroscience-focused drug discovery and development programs.

Amendment 1 Attached - Q&A posted

Update #1 ·

Statement of Need and Purpose: The NIH is seeking executive (senior scientific)-level, industry-experienced drug discovery and development consultants with expertise in Medicinal Chemistry to provide technical guidance in the area of Medicinal Chemistry to the following programs:
• Medicinal Chemistry consulting to procure consultant services to provide technical recommendations to the NIH Blueprint Neurotherapeutics Network drug discovery and development programs.
• Help End Addiction Long-Term [HEAL] initiative. The HEAL initiative aims to optimize non-addictive therapies [small molecules and biologics] to treat pain.
• Other NIH neuroscience-focused drug discovery and development programs.

Files

Show all 11

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors